Loading
RANO-BM is the set of rules for judging whether cancer that has spread to the brain is responding, stable or growing in a clinical trial.
Patients with brain metastases were long excluded from trials, and those trials that included them used varying response and progression criteria. The RANO Brain Metastases working group (Lin and colleagues, Lancet Oncology 2015) proposed standard response and progression criteria for brain metastases in clinical trials, to make results comparable.
Showing the technology this term belongs to: MRI.
Shares RANO criteria (brain tumour response), MRI.
Shares RANO criteria (brain tumour response), MRI.
Shares RANO criteria (brain tumour response), MRI.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/